PMEF
VBIV

Point72 Middle East FZE’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Point72 Middle East FZE’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-421
Closed -$4.94K – 2331
2022
Q4 		$4.94K Buy
+421
New +$7.43K ﹤0.01% 1778

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Middle East FZE's VBIV Position: Q1 2023 in Review

Point72 Middle East FZE sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2023, closing a stake of 421 shares — an estimated $4.94K sold.

Point72 Middle East FZE first reported a position in VBIV in Q4 2022 and held it in 1 quarter. The position peaked at $4.94K in Q4 2022. 95 funds tracked by Wall St. Rank hold VBIV as of Q1 2023.

  • Point72 Middle East FZE reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 421 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2023, an estimated $4.94K.
  • Point72 Middle East FZE first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2022 and held it in 1 quarter.
  • Point72 Middle East FZE's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $4.94K in Q4 2022.
  • 95 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2023.

Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.